Kevin Norrett is the Chief Operating Officer at Codexis, Inc., a biotechnology company focused on creating solutions for a more sustainable world. He has extensive experience in the biopharmaceutical industry, previously holding key positions like Chief Business Officer at Sierra...
Kevin Norrett is the Chief Operating Officer at Codexis, Inc., a biotechnology company focused on creating solutions for a more sustainable world. He has extensive experience in the biopharmaceutical industry, previously holding key positions like Chief Business Officer at Sierra Oncology and Chief Commercial Officer at Angion Biomedica. Kevin has a strong educational background with an M.B.A. from UC Berkeley, and before that, he earned degrees in Biological Sciences and Biochemistry from UC Davis and UCLA, respectively. In 2023, he earned a total compensation of about $1.09 million, which includes base salary, bonuses, and stock options. His recent insider trading activity suggests he has confidence in the company’s future, with notable trades throughout 2023 totaling over $4 million. Since joining Codexis in October 2022, he has been an integral part of the team, working to boost the company's mission and performance.